Astellas Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 19, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	24,304	15,998	18,058	23,412	26,092	24,354
Market Cap Growth	44.72%	-11.41%	-22.87%	-10.27%	7.14%	-7.27%
Enterprise Value	26,894	20,542	21,852	20,799	23,501	22,002
Last Close Price	13.38	8.55	9.10	11.49	12.08	10.99
PE Ratio	13.86	51.03	172.88	34.26	28.37	26.22
PS Ratio	2.17	1.35	1.84	2.23	2.72	2.53
PB Ratio	2.54	1.71	1.85	2.24	2.41	2.28
P/TBV Ratio	16.27	-	-	5.48	6.59	7.02
P/FCF Ratio	10.99	16.44	21.92	11.61	15.53	11.48
P/OCF Ratio	9.77	13.31	17.09	10.32	13.67	10.30
EV/Sales Ratio	2.38	1.74	2.22	1.98	2.45	2.29
EV/EBITDA Ratio	8.08	7.19	12.63	8.90	10.64	8.83
EV/EBIT Ratio	11.82	12.62	28.62	12.97	14.53	11.38
EV/FCF Ratio	12.16	21.11	26.53	10.31	13.98	10.37
Debt / Equity Ratio	0.41	0.62	0.63	0.14	0.15	0.20
Debt / EBITDA Ratio	1.19	2.03	3.57	0.61	0.72	0.86
Debt / FCF Ratio	1.78	5.95	7.50	0.70	0.94	1.01
Net Debt / Equity Ratio	0.27	0.50	0.42	-0.11	-0.07	-0.03
Net Debt / EBITDA Ratio	0.77	1.62	2.38	-0.51	-0.34	-0.15
Net Debt / FCF Ratio	1.16	4.75	5.00	-0.59	-0.45	-0.17
Asset Turnover	0.58	0.55	0.53	0.63	0.56	0.54
Inventory Turnover	1.27	1.28	1.38	1.76	1.60	1.56
Quick Ratio	0.79	0.79	0.69	1.13	1.05	1.15
Current Ratio	1.09	1.13	0.93	1.45	1.34	1.47
Return on Equity (ROE)	19.81%	3.26%	1.10%	6.65%	8.72%	9.01%
Return on Assets (ROA)	7.38%	4.77%	2.58%	6.05%	5.92%	6.83%
Return on Invested Capital (ROIC)	16.07%	11.63%	4.72%	12.83%	12.80%	15.28%
Return on Capital Employed (ROCE)	18.30%	11.60%	5.50%	13.40%	13.30%	14.90%
Earnings Yield	7.22%	1.96%	0.58%	2.92%	3.52%	3.81%
FCF Yield	9.10%	6.08%	4.56%	8.62%	6.44%	8.71%
Dividend Yield	3.34%	5.35%	4.71%	3.62%	3.07%	2.94%
Payout Ratio	42.15%	254.19%	684.38%	101.66%	68.69%	63.15%
Buyback Yield / Dilution	-0.64%	0.14%	1.39%	1.38%	0.41%	1.03%
Total Shareholder Return	2.70%	5.49%	6.11%	5.00%	3.48%	3.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.